Literature DB >> 1310957

Detection of Epstein-Barr virus sequences in patients with Kawasaki disease by means of the polymerase chain reaction.

H Kikuta1, M Nakanishi, N Ishikawa, M Konno, S Matsumoto.   

Abstract

We used a selective DNA amplification technique to detect Epstein-Barr virus (EBV) DNA in peripheral blood mononuclear cells from patients with Kawasaki disease (KD). By means of the polymerase chain reaction EBV sequences were indentified directly in 21 (60%) of 35 KD patients within 2 weeks after the onset of KD. Furthermore, EBV sequences were detected in all of 6 repeatedly tested patients with KD within 3 months after disease onset. In contrast, only 2 (12%) of 17 control DNA samples were polymerase chain reaction positive. These results indicate that an unusual EBV-cell interaction may exist in KD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310957     DOI: 10.1159/000150224

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  4 in total

1.  Kawasaki disease, Epstein-Barr virus and coronary artery aneurysms.

Authors:  G A Culora; I E Moore
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

2.  Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease.

Authors:  Kazuya Shirato; Yoshio Imada; Miyuki Kawase; Keiko Nakagaki; Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Med Virol       Date:  2014-04-24       Impact factor: 2.327

3.  Case Report: Pediatric Chronic Active Epstein-Barr Virus Infection With Giant Sinus of Valsalva Aneurysms and Aorta and Its Branch Dilations.

Authors:  Qirui Li; Guyu Li; Daming Shao; Tharak Yarrabolu; Yuan Yue
Journal:  Front Pediatr       Date:  2022-01-31       Impact factor: 3.418

4.  Kawasaki disease with a concomitant primary Epstein - Barr virus infection.

Authors:  Nataly Rosenfeld; Diana Tasher; Adi Ovadia; Shirly Abiri; Ilan Dalal
Journal:  Pediatr Rheumatol Online J       Date:  2020-08-12       Impact factor: 3.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.